External Link Confirmation
You are about to visit:
https://bio.nikkeibp.co.jp/atcl/news/p1/25/07/08/13509/
Title:
大鵬薬品工業、DMD患者にHPGDS阻害薬を投与する国内第3相で主要評価項目が未達
Source:
日経バイオテクONLINE
You're leaving TrendXday.com. Please be careful when visiting external sites.